Connect with us

Coronavirus Outbreak

Potential Coronavirus Vaccine Enters Human Testing In The United States

The trial began by administering the first five vaccinations to people Monday (May 4). The vaccine uses a gene-based technology known as messenger RNA

Potential Coronavirus Vaccine Enters Human Testing In The United States
Highlights
  • The trial has begun with healthy, young people aged between 18 and 55
  • Study will be expanded to an older group - people up to age 85
  • Study is being conducted on 360 people, results could come next month

Washington: United States-based pharmaceutical giant Pfizer has begun testing multiple versions of an experimental vaccine in healthy young people in America. Pfizer has partnered with Germany’s BioNTech SE to explore a potential defence against the respiratory disease over 2.5 lakh people worldwide, Wall Street Journal reported. Researchers at the New York University Grossman School of Medicine in Manhattan and the University of Maryland School of Medicine in Baltimore on Tuesday (May 5) said that they have begun injecting volunteers with the first of four vaccine candidates from Pfizer and Germany’s BioNTech.

Also Read: How Long Will The World Have To Wait For A Vaccine Against COVID-19? Experts Answer

The trial began by administering the first five vaccinations to people Monday (May 4). The vaccine uses a gene-based technology known as messenger RNA.

The trial has begun with healthy, young people between the ages of 18 and 55. But as safety is established in that population, it will expand to an older group of study participants — people up to age 85.

Also Read: Vaccine Will Be Effective Even If Coronavirus Mutates: ICMR

The trial will help the researchers to evaluate that the vaccine candidates are safe, which produces the strongest immune response that could fend off the coronavirus and what the doses should be.

The study is being conducted on 360 people whose results could come as early as next months. However, the vaccine will still need to undergo additional testing in more patients, said Kathrin Jansen, Pfizer’s head of vaccine research and development.

Also Read: Coronavirus Outbreak Explained: What Are The Four Types Of Vaccines Being Worked On To Fight Coronavirus?

Kathrin Jansen said that they will track the progress of the study to pick the most promising vaccine candidate.

Pfizer Chief Executive Albert Bourla told The Wall Street Journal last week that a vaccine against coronavirus could be ready for emergency use as early as the falls if everything goes well.

Several potential coronavirus vaccines have entered human testing, including candidates from Moderna Inc. and Oxford University.

Also Read: Out of 100 Active Projects In The World To Develop COVID-19 Vaccine, There Are Six Indian Companies

World

23,23,25,643Cases
19,46,11,603Active
3,29,58,002Recovered
47,56,038Deaths
Coronavirus has spread to 195 countries. The total confirmed cases worldwide are 23,23,25,643 and 47,56,038 have died; 19,46,11,603 are active cases and 3,29,58,002 have recovered as on September 28, 2021 at 3:48 am.

India

3,36,97,581 18,795Cases
2,92,2067,414Active
3,29,58,002 26,030Recovered
4,47,373 179Deaths
In India, there are 3,36,97,581 confirmed cases including 4,47,373 deaths. The number of active cases is 2,92,206 and 3,29,58,002 have recovered as on September 28, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

65,44,325

41,396 32

63,64,027

1,38,902 32

Kerala

46,41,587 11,699

1,57,733 6,122

44,59,193 17,763

24,661 58

Karnataka

29,73,899 504

12,833 409

29,23,320 893

37,746 20

Tamil Nadu

26,58,923 1,657

17,261 24

26,06,153 1,662

35,509 19

Andhra Pradesh

20,47,459 618

12,482 566

20,20,835 1,178

14,142 6

Uttar Pradesh

17,09,778 6

176 0

16,86,712 6

22,890

West Bengal

15,66,865 472

7,584 99

15,40,530 556

18,751 15

Delhi

14,38,746 32

366 5

14,13,295 37

25,085

Odisha

10,24,764 444

5,102 214

10,11,482 653

8,180 5

Chhattisgarh

10,05,269 27

282 3

9,91,423 30

13,564

Rajasthan

9,54,316 13

86 9

9,45,276 4

8,954

Gujarat

8,25,872 21

142 9

8,15,648 30

10,082

Madhya Pradesh

7,92,504 8

118 2

7,81,868 6

10,518

Haryana

7,70,825 7

329 6

7,60,686 13

9,810

Bihar

7,25,947 3

57 11

7,16,230 14

9,660

Telangana

6,65,284 216

4,585 27

6,56,785 241

3,914 2

Punjab

6,01,538 38

284 2

5,84,747 35

16,507 1

Assam

6,01,031 412

4,587 42

5,90,593 362

5,851 8

Jharkhand

3,48,198 4

79 1

3,42,986 5

5,133

Uttarakhand

3,43,504 14

218 8

3,35,893 22

7,393

Jammu And Kashmir

3,29,125 117

1,513 1

3,23,190 118

4,422

Himachal Pradesh

2,18,523 209

1,730 16

2,13,124 225

3,669

Goa

1,76,145 50

862 56

1,71,980 106

3,303

Puducherry

1,26,127 37

866 35

1,23,423 72

1,838

Manipur

1,20,000 116

2,111 14

1,16,042 129

1,847 1

Mizoram

90,539 1,846

15,843 358

74,394 1,481

302 7

Tripura

84,085 19

275 3

82,999 22

811

Meghalaya

80,897 108

1,752 125

77,750 230

1,395 3

Chandigarh

65,217 7

44 3

64,354 4

819

Arunachal Pradesh

54,395 43

319 4

53,802 47

274

Sikkim

31,291 25

601 11

30,303 35

387 1

Nagaland

31,167 17

426 19

30,078 35

663 1

Ladakh

20,786 5

148 8

20,431 13

207

Dadra And Nagar Haveli

10,670

0 0

10,666

4

Lakshadweep

10,361

5 0

10,305

51

Andaman And Nicobar Islands

7,619 1

11 2

7,479 3

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Leaving No One Behind

Mental Health

Environment

Join Us